AU3247593A - Therapeutic combinations useful in the treatment of gastroesophageal reflux disease - Google Patents

Therapeutic combinations useful in the treatment of gastroesophageal reflux disease

Info

Publication number
AU3247593A
AU3247593A AU32475/93A AU3247593A AU3247593A AU 3247593 A AU3247593 A AU 3247593A AU 32475/93 A AU32475/93 A AU 32475/93A AU 3247593 A AU3247593 A AU 3247593A AU 3247593 A AU3247593 A AU 3247593A
Authority
AU
Australia
Prior art keywords
treatment
reflux disease
gastroesophageal reflux
therapeutic combinations
combinations useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU32475/93A
Inventor
David Christopher Horwell
John Cureton Hunter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of AU3247593A publication Critical patent/AU3247593A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU32475/93A 1991-12-20 1992-12-11 Therapeutic combinations useful in the treatment of gastroesophageal reflux disease Abandoned AU3247593A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81148791A 1991-12-20 1991-12-20
US811487 1991-12-20

Publications (1)

Publication Number Publication Date
AU3247593A true AU3247593A (en) 1993-07-28

Family

ID=25206680

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32475/93A Abandoned AU3247593A (en) 1991-12-20 1992-12-11 Therapeutic combinations useful in the treatment of gastroesophageal reflux disease

Country Status (2)

Country Link
AU (1) AU3247593A (en)
WO (1) WO1993012817A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1003554E (en) 1997-07-25 2005-03-31 Altana Pharma Ag PUMP INHIBITOR IN THERAPEUTIC COMBINATION WITH ANTIBACTERIAL SUBSTANCES
GB9911017D0 (en) * 1999-05-13 1999-07-14 Zeneca Ltd Pharmaceutical compositions
IL145220A0 (en) * 1999-05-20 2002-06-30 Par Pharmaceutical Inc Stabilized composition based on pyridinyl-sulfinyl-benzimidazoles and process
SE0000774D0 (en) 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
AU2001253024A1 (en) * 2000-04-10 2001-10-23 The General Hospital Corporation Diagnosis and treatment of gastrointestinal disease
GB0011092D0 (en) * 2000-05-08 2000-06-28 Black James Foundation Gastrin and cholecystokinin receptor ligands (III)
GB0011098D0 (en) * 2000-05-08 2000-06-28 Black James Foundation Pharmaceutical compositions comprising protpn pump inhibitors and gastrin/cholecystokinin receptor ligands
ATE474559T1 (en) 2001-06-01 2010-08-15 Pozen Inc PHARMACEUTICAL COMPOSITIONS FOR COORDINATED DELIVERY OF NSAIDS
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
SE0102993D0 (en) 2001-09-07 2001-09-07 Astrazeneca Ab New self emulsifying drug delivery system
US20060003993A1 (en) * 2001-11-13 2006-01-05 James Black Foundation Limited Benzotriazepnes as gastrin and cholecystokinin receptor ligands
US7524837B2 (en) 2003-05-12 2009-04-28 Janssen Pharmaceutica N.V. Benzotriazapinone salts and methods for using same
GB0425196D0 (en) * 2004-11-15 2004-12-15 Black James Foundation Gastrin and cholecystokinin receptor ligands
ATE425791T1 (en) * 2005-07-29 2009-04-15 Rottapharm Spa COMBINATION OF ITRIGLUMIDE AND PPI FOR THE TREATMENT OF GASTROINTESTINAL AND ASSOCIATED DISEASES
US7863330B2 (en) 2006-06-14 2011-01-04 Rottapharm S.P.A. Deloxiglumide and proton pump inhibitor combination in the treatment of gastrointestinal disorders
KR20110079641A (en) 2008-09-09 2011-07-07 아스트라제네카 아베 Method for delivering a pharmaceutical composition to patient in need thereof
AU2010263304A1 (en) 2009-06-25 2012-02-02 Astrazeneca Ab Method for treating a patient at risk for developing an NSAID-associated ulcer
EP2797600A4 (en) 2011-12-28 2015-09-16 Pozen Inc Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
CN106163527A (en) 2013-11-22 2016-11-23 Cl生物科技有限责任公司 For treating and preventing the gastrin antagonists of osteoporosis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8630080D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments

Also Published As

Publication number Publication date
WO1993012817A1 (en) 1993-07-08

Similar Documents

Publication Publication Date Title
AU3247593A (en) Therapeutic combinations useful in the treatment of gastroesophageal reflux disease
AU2845492A (en) Dipyridamole for the treatment of proliferative diseases
PL318760A1 (en) Spiroazabicyclo compounds useful in medical treatment
CY2007001I2 (en) MEDICINAL PREPARATION FOR USE IN THE TREATMENT OF DIABETES
AU4676997A (en) Methods of using (-) cisapride for the treatment of gastro-esophageal reflux disease and other disorders
EP0651639A4 (en) Methods of using (+) cisapride for the treatment of gastro-esophageal reflux disease and other disorders.
GB2243296B (en) Treatment of disease associated with hiv-infections
AU1197992A (en) The use of loperamide and related compounds for treatment of respiratory disease symptoms
AU3397089A (en) Hard tissue surface treatment
AU2466695A (en) The use of famotidine and related compounds in the treatment of movement disorders
AU5590696A (en) Use of quinones in the treatment of cancer or AIDS
AU2807492A (en) Use of misoprostol for the treatment of allergy
AU7384094A (en) Use of phenethanolamine derivatives in the treatment of gastrointestinal disorders
AU9052991A (en) Use of angiotensin ii antagonist in the treatment of infarction
EP0437026A3 (en) Use of tandospirone in the treatment of depression
EP0496148A3 (en) Improvements in the treatment of ashes
AU8185491A (en) Treatment of disease
GB9217124D0 (en) Medical treatment
AU6491890A (en) Use of arylalkylamides in the treatment of neurodegenerative diseases
GB2275191B (en) Use of antifungal compounds in the treatment of skin disorders
AU1931895A (en) Treatment of graft-versus-host disease
HUP9800272A3 (en) Use of penciclovir for the treatment of human herpes-virus-8
ZA9610264B (en) Preparation for use in the treatment of skin disorders.
HUP0000570A3 (en) Use of 17 alpha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
AU2395288A (en) Metoprolol in the treatment and prophylaxis of heart disease